Greenwich LifeSciences, Inc.

NASDAQ:GLSI

14.17 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 000.0050000000000000000000
Cost of Revenue 0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.00100000000
Gross Profit -0.001-0.0010.005-0.001-0.001-0.001-0.001-0.001-0.001-0.001-0.001-0.001-0.001-0.00100000000
Gross Profit Ratio 000.8330000000000000000000
Reseach & Development Expenses 2.3082.1952.3332.1581.381.8282.4581.7230.6331.6612.0640.6570.5570.2820.5990.1580.1510.150.2590.2851.9370.126
General & Administrative Expenses 0.3540.3430.5030.3450.3680.4130.4370.660.140.3280.3130.210.1970.3190.5530.0990.060.0950.0780.0520.6670.022
Selling & Marketing Expenses -0.001-0.001-0.0010000000000000000000
SG&A 0.3530.3420.5020.3450.3680.4130.4370.660.140.3280.3130.210.1970.3190.5530.0990.060.0950.0780.0520.6670.022
Other Expenses 02.19500000000000000000000
Operating Expenses 2.6612.5362.8352.5031.7482.2412.8952.3830.7731.9892.3770.8670.7530.6011.1520.2570.210.2450.3370.3362.6040.149
Operating Income -2.661-2.537-2.836-2.503-1.748-2.241-2.895-2.383-0.773-1.989-2.377-0.867-0.753-0.601-1.152-0.257-0.21-0.245-0.337-0.336-2.604-0.149
Operating Income Ratio 00-523.4460000000000000000000
Total Other Income Expenses Net 0.0550.0640.0890.1110.1190.1160.1040.0640.0270.020.0170.0040.0040.004-0.7110000000
Income Before Tax -2.607-2.473-2.747-2.392-1.628-2.125-2.791-2.319-0.746-1.97-2.361-0.863-0.75-0.597-1.151-0.257-0.21-0.245-0.337-0.336-2.604-0.149
Income Before Tax Ratio 00-506.9650000000000000000000
Income Tax Expense -0-2.538-00.04-0.121-0.116-0.151-0.064-0.027-0.020000-0.71200000-0.0010
Net Income -2.607-2.473-2.747-2.392-1.628-2.009-2.64-2.255-0.719-1.95-2.361-0.863-0.75-0.597-1.151-0.257-0.21-0.245-0.337-0.336-2.604-0.149
Net Income Ratio 00-506.9650000000000000000000
EPS -0.2-0.19-0.21-0.19-0.13-0.16-0.21-0.18-0.056-0.15-0.18-0.067-0.058-0.047-0.13-0.022-0.018-0.02-0.028-0.028-0.22-0.74
EPS Diluted -0.2-0.19-0.21-0.19-0.13-0.16-0.21-0.18-0.056-0.15-0.18-0.067-0.058-0.047-0.13-0.022-0.018-0.02-0.028-0.028-0.22-0.73
EBITDA -2.661-2.536-2.835-2.502-1.747-2.24-2.894-2.382-0.772-1.988-2.376-0.866-0.753-0.6-1.151-0.256-0.21-0.244-0.336-0.335-2.604-0.148
EBITDA Ratio 00-523.280000000000000000000